new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Exelixis Inc
Exelixis Inc_20131212
  

Exelixis Inc patents

Recent patent applications related to Exelixis Inc. Exelixis Inc is listed as an Agent/Assignee. Note: Exelixis Inc may have other listings under different names/spellings. We're not affiliated with Exelixis Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "E" | Exelixis Inc-related inventors




Date Exelixis Inc patents (updated weekly) - BOOKMARK this page
03/30/17Dosing of cabozantinib formulations
03/02/17Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
02/16/17Method of treating lung adenocarcinoma
02/16/17Crystalline solid forms of n--n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
08/11/16Process for preparing quinoline derivatives
08/04/16Method of treating cancer
06/30/16C-met modulators and use
03/24/16Drug combinations to treat cancer
02/25/16Method of treating cancer
02/04/16Metabolites of n-(4-phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
01/28/16Cabozantinib dosage form and use in the treatment of cancer
01/07/16Methods of using c-met modulators
12/31/15C-met modulators and methods of use
09/24/15Rorgamma modulators
08/27/15Method of treating lung adenocarcinoma
07/30/15Novel process for making compounds for use in the treatment of cancer
07/23/15Methods of using c-met modulators
07/16/15Method of treating cancer
05/21/15Mek inhibitors and methods of their use
05/14/15Method of treating cancer
02/26/15Malate salt of n-(4-phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
12/25/14Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
10/09/14Combination therapies for treating hematologic malignancies using pyridopyrimidinone inhibitors of pi3k/mtor with bendamustine and/or rituximab
10/09/14Inhibitors of pi3k-delta and methods of their use and manufacture
10/09/14Phosphatidylinositol 3-kinase inhibitors for the treatment of lymphoproliferative malignancies
10/02/14Method of treating lymphoma using pyridopyrimidinone inhibitors of pi3k/mtor
09/18/14Azetidines as mek inhibitors for the treatment of proliferative diseases
08/14/14Method for treating osteoporosis
07/17/14Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
07/03/14C-met modulator pharmaceutical compositions
06/26/14Method of treating cancer and bone cancer pain
06/05/14C-met modulators and use
05/01/14Method of treating lung adenocarcinoma
04/17/14Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
04/10/14Methods of using pi3k and mek modulators
03/20/14Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
03/06/14Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
03/06/14Method of treating cancer
02/27/14Method of treating cancer
02/27/14Inhibitors of pi3k-delta and methods of their use and manufacture
02/13/14Inhibitors of pi3k-delta and methods of their use and manufacture
01/23/14Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
01/16/14Benzoxazepines as inhibitors of mtor and methods of their use and manufacture
12/26/13Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treament of cancer
12/12/13C-met modulator pharmaceutical compositions
09/26/13C-met modulators and use
08/15/13Pfks as modifiers of the igfr pathway and methods of use
07/04/13Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k and mtor in combination with autophagy inhibitors
06/27/13Jak1 inhibitors
06/06/13Hydrated crystalline forms of n-[3-fluoro-4-(oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
01/31/13Methods of preparing quinoline derivatives
11/29/12Method of using pi3k and mek modulators
11/08/12Methods of using c-met modulators
10/25/12Crystalline forms of n-[3-fluoro-4-(oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
10/11/12Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
10/04/12Method of treating cancer
07/19/12C-met modulators and use
05/03/12Psmcs as modifiers of the rb pathway and methods of use
03/22/12Methods of using c-met modulators
03/15/12Quinazolinone modulators of nuclear receptors
02/09/12(l)-malate salt of n-(4-phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
01/26/12C-met modulators and use
12/08/11Pyrrole derivatives as pharmaceutical agents
12/08/11Synergistic effects between sphingosine-1-phosphate receptor antagonists and antimicrotubule agents
11/24/11Sphingosine-1-phosphate receptor antagonists
Patent Packs
10/27/111-phenylpyrrole derivatives
10/27/11Azetidines as mek inhibitors for the treatment of proliferative diseases
10/27/11Atropisomers of (hydroxyalkyl) pyrrole derivatives
09/29/11Pyridopyrimidinone inhibitors of pi3kalpha
08/25/11Phosphatidylinositol 3-kinase inhibitors and methods of their use
08/18/11Cdk modulators
07/07/11Gfats as modifiers of the axin pathway and methods of use
06/30/11Gfats as modifiers of the p53 pathway and methods of use
06/16/11Heterocyclic carboxamide compounds as steroid nuclear receptors ligands
06/09/11Eya2s as modifiers of the pten/akt pathway and methods of use
05/26/11Combination therapies comprising quinoxaline inhibitors of p13k-alpha for use in the treatment of cancer
05/12/11Kifs as modifiers of the rho pathway and methods of use
03/31/11C-met modulators and use
03/24/11Raf modulators and methods of use
03/10/11Paks as modifiers of the chk pathway and methods of use
Patent Packs
02/10/11Csnks as modifiers of the rac pathway and methods of use
01/27/11P70s6 kinase modulators and use
12/30/10Modulators of lxr
12/23/10Marks as modifiers of the p53 pathway and methods of use
12/02/10Inhibitors of mtor and methods of making and using
11/25/10Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
10/28/10Hadhs as modifiers of the p21 pathway and methods of use
09/30/10Modulators of s1p and methods of making and using
09/30/10Azetidines as mek inhibitors for the treatment of proliferative diseases
08/19/10Methods of treating cancer using pyridopyrimidinone inhibitors of p13k alpha
07/22/10Galk1s as modifiers of the pten/akt pathway and methods of use
07/08/10Azepinoindole derivatives as pharmaceutical agents
06/24/10Scds as modifiers of the p53 pathway and methods of use
06/24/10S1p1 agonists and methods of making and using
06/17/10Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treatment of cancer
06/10/10Pyrimidinones as casein kinase ii (ck2) modulators
06/03/106-phenylpyrimidinones as pim modulators
06/03/10Jak-2 modulators and methods of use
05/27/10Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators
05/13/10Cdc6s as modifiers of the pten/akt pathway and methods of use
04/29/1011 beta-hsd1 modulators
04/08/10Pyridopyrimidinone inhibitors of pi3k-alpha and mtor
03/25/10Methods of using pi3k and mek modulators
03/25/10Imidazole based lxr modulators
03/18/10Lxr and fxr modulators
12/31/09Azepinoindole and pyridoindole derivatives as pharmaceutical agents
12/03/094-aryl-2-amino-pyrimidnes or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and methods of use
10/01/0911 beta-hsd1 modulators
10/01/09Benzofuropyrimidinones
09/17/09Methods of using igfir and abl kinase modulators
Social Network Patent Pack
08/13/09C20orf23 as modifier of the igfr pathway and methods of use
08/13/09Azepinoindole derivatives as pharmaceutical agents
08/06/09Pharmaceutical compositions
07/23/09Anaplastic lymphoma kinase modulators and methods of use
07/02/09C-met modulators and methods of use
06/18/09Azetidines as mek inhibitors for the treatment of proliferative diseases
06/11/09Rors as modifiers of the p21 pathway and methods of use
06/04/09Pfks as modifiers of the igfr pathway and methods of use
04/23/09C-met modulators and methods of use
04/23/09Inhibitors of hedgehog pathway
Patent Packs
03/12/09Map3ks as modifiers of the p53 pathway and methods of use
03/05/09Pyridopyrimidinone inhibitors of pi3kalpha
02/26/09Acacs as modifiers of the igf pathway and methods of use
12/12/13C-met modulator pharmaceutical compositions







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Exelixis Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Exelixis Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';